Liver Diseases  >>  tenofovir disoproxil fumarate  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tenofovir disoproxil fumarate / Generic mfg.
NCT01671787: A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Completed
1b
51
Canada, US, Europe, RoW
GS-7340, Tenofovir disoproxil fumarate, Viread
Gilead Sciences
Chronic Hepatitis B
04/13
04/13
NCT00828789: VX-950-TiDP24-C134: Drug-drug Interaction Trial Between Combination of Efavirenz and Tenofovir Disoproxil Fumarate and Different Dosages of Telaprevir on Healthy Volunteer

Completed
1
20
RoW
Efavirenz; Tenofovir disoproxil fumarate; Telaprevir
Tibotec BVBA
Hepatitis C, HCV, HIV, AIDS
04/09
04/09
NCT01205139: TMC435-TiDP16-C114 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents TMC278 and Tenofovir

Completed
1
48
Europe
TMC435, TDF, TMC435 + TDF, TMC435 + TMC278, TMC278
Tibotec Pharmaceuticals, Ireland
Hepatitis C Virus
03/11
03/11
NCT01480622: Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese Subjects

Completed
1
14
RoW
TDF tablets
GlaxoSmithKline
Hepatitis B, Chronic
12/11
12/11

Download Options